424 related articles for article (PubMed ID: 28215163)
1. Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance.
Lanzi C; Zaffaroni N; Cassinelli G
Curr Med Chem; 2017; 24(26):2860-2886. PubMed ID: 28215163
[TBL] [Abstract][Full Text] [Related]
2. Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunities.
Lanzi C; Cassinelli G
Biochem Pharmacol; 2020 Aug; 178():114084. PubMed ID: 32526230
[TBL] [Abstract][Full Text] [Related]
3. The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomas.
Cassinelli G; Zaffaroni N; Lanzi C
Cancer Lett; 2016 Nov; 382(2):245-254. PubMed ID: 27666777
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.
Sanderson RD; Yang Y; Kelly T; MacLeod V; Dai Y; Theus A
J Cell Biochem; 2005 Dec; 96(5):897-905. PubMed ID: 16149080
[TBL] [Abstract][Full Text] [Related]
5. Heparan Sulfate in the Tumor Microenvironment.
Bartolini B; Caravà E; Caon I; Parnigoni A; Moretto P; Passi A; Vigetti D; Viola M; Karousou E
Adv Exp Med Biol; 2020; 1245():147-161. PubMed ID: 32266657
[TBL] [Abstract][Full Text] [Related]
6. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate proteoglycans in cancer: Pathogenesis and therapeutic potential.
Yang H; Wang L
Adv Cancer Res; 2023; 157():251-291. PubMed ID: 36725112
[TBL] [Abstract][Full Text] [Related]
8. Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment.
De Pasquale V; Pavone LM
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916872
[TBL] [Abstract][Full Text] [Related]
9. The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.
Hammond E; Khurana A; Shridhar V; Dredge K
Front Oncol; 2014; 4():195. PubMed ID: 25105093
[TBL] [Abstract][Full Text] [Related]
10. Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer.
Fernández-Vega I; García O; Crespo A; Castañón S; Menéndez P; Astudillo A; Quirós LM
BMC Cancer; 2013 Jan; 13():24. PubMed ID: 23327652
[TBL] [Abstract][Full Text] [Related]
11. Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.
Baburajeev CP; Mohan CD; Rangappa S; Mason DJ; Fuchs JE; Bender A; Barash U; Vlodavsky I; Basappa ; Rangappa KS
BMC Cancer; 2017 Mar; 17(1):235. PubMed ID: 28359266
[TBL] [Abstract][Full Text] [Related]
12. Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme.
Tayel A; Abd El Galil KH; Ebrahim MA; Ibrahim AS; El-Gayar AM; Al-Gayyar MM
Eur J Pharmacol; 2014 Apr; 728():151-60. PubMed ID: 24530413
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial roles of heparan sulfate proteoglycans and heparan sulfates in Caenorhabditis elegans neural development.
Kinnunen TK
PLoS One; 2014; 9(7):e102919. PubMed ID: 25054285
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma.
Reijmers RM; Spaargaren M; Pals ST
FEBS J; 2013 May; 280(10):2180-93. PubMed ID: 23419151
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the discovery of heparanase inhibitors as anti-cancer agents.
Jia L; Ma S
Eur J Med Chem; 2016 Oct; 121():209-220. PubMed ID: 27240275
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of heparanase inhibitors in cancer therapy.
Heyman B; Yang Y
Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132
[TBL] [Abstract][Full Text] [Related]
17. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development.
Vlodavsky I; Goldshmidt O; Zcharia E; Atzmon R; Rangini-Guatta Z; Elkin M; Peretz T; Friedmann Y
Semin Cancer Biol; 2002 Apr; 12(2):121-9. PubMed ID: 12027584
[TBL] [Abstract][Full Text] [Related]
18. Heparan Sulfate Proteoglycans as Relays of Neuroinflammation.
O'Callaghan P; Zhang X; Li JP
J Histochem Cytochem; 2018 Apr; 66(4):305-319. PubMed ID: 29290138
[TBL] [Abstract][Full Text] [Related]
19. Metalloglycomics.
Farrell NP; Gorle AK; Peterson EJ; Berners-Price SJ
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394023
[TBL] [Abstract][Full Text] [Related]
20. The Good and Bad Sides of Heparanase-1 and Heparanase-2.
Pinhal MAS; Melo CM; Nader HB
Adv Exp Med Biol; 2020; 1221():821-845. PubMed ID: 32274740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]